Trifluridine/Tipiracil Plus Bevacizumab Versus Regorafenib in Elderly Patients with Refractory Metastatic Colorectal Cancer: A Real-World Comparative Study.

Saved in:
Bibliographic Details
Title: Trifluridine/Tipiracil Plus Bevacizumab Versus Regorafenib in Elderly Patients with Refractory Metastatic Colorectal Cancer: A Real-World Comparative Study.
Authors: Tseng, Yu-Kang1 (AUTHOR), Lin, Chang-Lin1 (AUTHOR) dc19871223@gmail.com, Chiang, Shih-Wei1 (AUTHOR), Chiang, Feng-Fan1 (AUTHOR)
Source: Cancers. Mar2026, Vol. 18 Issue 5, p788. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18050788